Heping Wang

691 total citations
19 papers, 493 citations indexed

About

Heping Wang is a scholar working on Genetics, Cancer Research and Molecular Biology. According to data from OpenAlex, Heping Wang has authored 19 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 5 papers in Cancer Research and 4 papers in Molecular Biology. Recurrent topics in Heping Wang's work include Glioma Diagnosis and Treatment (5 papers), Advancements in Transdermal Drug Delivery (2 papers) and Cancer Research and Treatments (2 papers). Heping Wang is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Advancements in Transdermal Drug Delivery (2 papers) and Cancer Research and Treatments (2 papers). Heping Wang collaborates with scholars based in China and United States. Heping Wang's co-authors include Lihong He, Minjie Zhang, Xiaoyue Chen, Zhiguo Zhang, Fang Dong, Ian F. Parney, Caterina Giannini, Jann N. Sarkaria, Jeong‐Heon Lee and Fredric B. Meyer and has published in prestigious journals such as Nature Communications, PLoS ONE and Clinical Chemistry.

In The Last Decade

Heping Wang

19 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Heping Wang China	11	246	144	135	96	60	19	493
Xiangjun Tang China	15	309 1.3×	119 0.8×	61 0.5×	46 0.5×	93 1.6×	28	552
Minhyung Lee South Korea	13	388 1.6×	100 0.7×	67 0.5×	14 0.1×	33 0.6×	26	551
Alessandro Barberis Italy	13	199 0.8×	111 0.8×	16 0.1×	48 0.5×	74 1.2×	23	460
Xiaoning Lin China	11	357 1.5×	157 1.1×	52 0.4×	32 0.3×	109 1.8×	27	713
Ana R. Rama Spain	15	301 1.2×	138 1.0×	27 0.2×	34 0.4×	194 3.2×	33	555
Xiujie Wu China	12	206 0.8×	91 0.6×	53 0.4×	35 0.4×	35 0.6×	20	392
Aihua Gong China	11	223 0.9×	109 0.8×	47 0.3×	28 0.3×	61 1.0×	16	405
Fazel Sahraneshin Samani Iran	11	198 0.8×	47 0.3×	131 1.0×	32 0.3×	73 1.2×	15	457
Hongzhi Xu China	13	118 0.5×	40 0.3×	37 0.3×	30 0.3×	47 0.8×	28	374
Dongye Yang China	7	199 0.8×	58 0.4×	31 0.2×	24 0.3×	58 1.0×	18	417

Countries citing papers authored by Heping Wang

Since Specialization

Citations

This map shows the geographic impact of Heping Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heping Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heping Wang more than expected).

Fields of papers citing papers by Heping Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heping Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heping Wang. The network helps show where Heping Wang may publish in the future.

Co-authorship network of co-authors of Heping Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Heping Wang. A scholar is included among the top collaborators of Heping Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heping Wang. Heping Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

David, C. Immanuel, et al.. (2025). An albumin-based indicator displacement assay enables ratiometric detection of total ochratoxins in food. Microchemical Journal. 212. 113215–113215. 2 indexed citations

Zeng, Tao, Bin Li, Xin Shu, et al.. (2023). Pan-cancer analysis reveals that G6PD is a prognostic biomarker and therapeutic target for a variety of cancers. Frontiers in Oncology. 13. 1183474–1183474. 9 indexed citations

Wang, Heping, Haitao Xu, Kehu Yang, et al.. (2023). BTN2A2, a new biomarker and therapeutic target for glioma. Aging. 15(20). 10996–11011. 3 indexed citations

Wang, Xiaoman, Heping Wang, Xiaoqiang Tang, et al.. (2022). Comprehensive assessment of cellular senescence in the tumor microenvironment. Briefings in Bioinformatics. 23(3). 55 indexed citations

Wang, Heping, Yan Li, Chunyan Wang, et al.. (2021). The enhancing effect and promoting mechanisms of the stereoisomeric monoterpene alcohol esters as enhancers for drugs with different physicochemical properties. Asian Journal of Pharmaceutical Sciences. 17(1). 139–152. 8 indexed citations

Wang, Xiaoxiong, et al.. (2021). Double-targeting CDCA8 and E2F1 inhibits the growth and migration of malignant glioma. Cell Death and Disease. 12(2). 146–146. 21 indexed citations

Zhu, Guanghui, Juan Li, Jie Li, et al.. (2021). The characteristics and related factors of insomnia among postoperative patients with gastric cancer: a cross-sectional survey. Supportive Care in Cancer. 29(12). 7315–7322. 12 indexed citations

Yang, Chao, et al.. (2021). MEX3A contributes to development and progression of glioma through regulating cell proliferation and cell migration and targeting CCL2. Cell Death and Disease. 12(1). 14–14. 26 indexed citations

Wang, Xinmiao, Guanghui Zhu, Shixin Li, et al.. (2021). Traditional Chinese Medicine Therapy for Esophageal Cancer: A Literature Review. Integrative Cancer Therapies. 20. 1543376856–1543376856. 17 indexed citations

10.

Wang, Chunyan, Jing Wang, Heping Wang, et al.. (2020). Chiral 4- O -acylterpineol as transdermal permeation enhancers: insights of the enhancement mechanisms of a transdermal enantioselective delivery system for flurbiprofen. Drug Delivery. 27(1). 723–735. 10 indexed citations

11.

Niu, Baolong, Jianhong Jia, Heping Wang, et al.. (2019). In vitro and in vivo release of diclofenac sodium-loaded sodium alginate/carboxymethyl chitosan-ZnO hydrogel beads. International Journal of Biological Macromolecules. 141. 1191–1198. 49 indexed citations

12.

Cheng, Fangling, Po Zhang, Qungen Xiao, et al.. (2019). The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma. Frontiers in Oncology. 9. 447–447. 8 indexed citations

13.

Chen, Xiaoyue, Minjie Zhang, Haiyun Gan, et al.. (2018). A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma. Nature Communications. 9(1). 2949–2949. 198 indexed citations

14.

Xiao, Qungen, Fangling Cheng, Feng Mao, et al.. (2018). LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling. International Journal of Oncology. 53(3). 1069–1082. 6 indexed citations

15.

Wang, Heping, et al.. (2017). Knockdown of Long Non-Coding RNA NEAT1 Inhibits Proliferation and Invasion and Induces Apoptosis of Osteosarcoma by Inhibiting miR-194 Expression. Yonsei Medical Journal. 58(6). 1092–1092. 27 indexed citations

16.

Wang, Guoxiang, et al.. (2014). Outcomes of Bronchial Artery Embolization for Life-Threatening Hemoptysis Secondary to Tuberculosis. PLoS ONE. 9(12). e115956–e115956. 23 indexed citations

17.

Wang, Peng, Lili Sheng, Guoxiang Wang, et al.. (2014). Association of transarterial chemoembolization with survival in patients with unresectable hepatocellular carcinoma. Molecular and Clinical Oncology. 2(2). 203–206. 11 indexed citations

18.

Pang, Na, et al.. (2007). An intensity-based personalized affective model. 2212–2215. 3 indexed citations

19.

Wang, Heping, et al.. (2003). Effects of LDL, Cholesterol, and Their Oxidized Forms on the Precipitation Kinetics of Calcium Phosphates. Clinical Chemistry. 49(12). 2027–2036. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact